+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Cancer Immunotherapy Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Pre Book Price: $ 5216

Original Price: $ 5795

 

Immunotherapy is a treatment option for various diseases such as cancer that uses certain parts of immune system to fight against the diseases. Immunotherapy is also known as biotherapy or biologic therapy. Immunotherapy can be performed via two ways:

  • By stimulating one’s own immune system to work against the disease by attacking defected cells
  • By giving components of immune system from outside such as synthetic proteins into the body to fight against disease

Immunotherapy is performed to treat cancer patients since long, even when immune system was not well understood by doctors. William, a New York surgeon, noticed that acquiring certain infections post surgery helped some cancer patients. In late 1800s, he started treating cancer patients by infecting them with Coley toxins (bacteria). Although he was successful in treating cancer, this technique was overshadowed by the introduction of other treatment options such as radiation therapy.

Later down the line, immunotherapy gained popularity with increasing knowledge about the actions of immune system. Immunotherapy has been proven to be successful in treating some type of cancer than other treatment options such as chemotherapy and radiation therapy. Immune system helps protect from infections by traveling throughout the body to protect it from germs that result infections. 

Cancer immunotherapy can be classified as: monoclonal antibodies therapy, cancer vaccines therapy and non-specific immunotherapy. Monoclonal antibodies are man-made versions of proteins for immune system. Antibodies are expected to be very useful in treating cancer since they are designed to attack specific parts of cancer cell. Cancer vaccines, also known as cell based therapy, help treat cancer by injecting certain substances (cancer vaccines) into the body to start an immune response against cancer. Non-specific immunotherapies boost the immune system in general way and help immune system to attack cancer cells.

Monoclonal antibodies can be further segmented as: naked monoclonal antibodies and conjugated monoclonal antibodies. The naked monoclonal antibodies are antibodies that are without any modifications or alterations. Currently, most of the antibodies therapies are performed with naked monoclonal antibodies. Conjugated monoclonal antibodies are modified by joining them to another molecule, which is either radioactive or toxic to cells. Toxic chemicals are generally routinely utilized chemotherapy drugs. The antibody binds to specific antigens on the cancer cells surface and directs the radiation or drugs to the tumor.

The market for cancer immunotherapy is expected to increase with rising number of patients suffering from cancer across the globe. It has been estimated by the World Cancer Research Fund International (WCRFI) that around 12.7 million people worldwide suffered from cancer in 2008 and this number is expected to reach nearly 21 million in 2030. Likewise, cancer immunotherapy has been proven to be successful in treating cancer which will expedite the utilization of cancer immunotherapy for cancer treatment. In addition, increasing research and development for cancer immunotherapy by scientists will further accentuate the growth of cancer immunotherapy market. Scientists have developed various new cancer vaccines and monoclonal antibodies for enhancing the list of cancer immunotherapy products. 

Some of the major payers operating in cancer immunotherapy market include Bristol-Myers Squibb, Viralytics, Ltd., Medivation, Inc., GlaxoSmithKline Pharmaceuticals Limited, Celgene Corp., Advaxis, Inc., Novartis Pharmaceuticals Corporation, Merck & Co., F. Hoffmann-La Roche Ltd. and AstraZeneca plc amongst other significant players.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of 

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report

  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segments 

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.


To receive discount, please click on the button below.

Please click on the button below to customize this report.

 
 
Back To Top